Concepedia

Darlene Dela Cruz

DD

4

Publications

303

Citations

4

H-Index

2016

Active since

Affiliations

Target (United States)(Current)

Darlene Dela Cruz is an author at Target (United States) specializing in tumor biology, medicine, and cell signaling.

Top concepts

Publications per year

2016–2021

4

Publications

4

ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

Ivana Yen, Jeeyun Lee, Yong Sang Hong et al. · Nature · 2021 · 133 citations · Full text

, , +6

Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent Tumorigenesis

Nisebita Sahu, Darlene Dela Cruz, Min Gao et al. · Cell Metabolism · 2016 · 112 citations · Full text

, , +7

Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs

Nisebita Sahu, Jean-Philippe Stéphan, Darlene Dela Cruz et al. · Nature Communications · 2016 · 36 citations · Full text

Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3 <i>H</i> )-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor

Malcolm P. Huestis, Darlene Dela Cruz, Antonio G. DiPasquale et al. · Journal of Medicinal Chemistry · 2021 · 22 citations · Full text

Rows per page

1–4 of 4